BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30969507)

  • 1. Treatment of Progressive Multifocal Leukoencephalopathy with Pembrolizumab.
    Rauer S; Marks R; Urbach H; Warnatz K; Nath A; Holland S; Weiller C; Grimbacher B
    N Engl J Med; 2019 Apr; 380(17):1676-1677. PubMed ID: 30969507
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Progressive Multifocal Leukoencephalopathy with Nivolumab.
    Walter O; Treiner E; Bonneville F; Mengelle C; Vergez F; Lerebours F; Delobel P; Liblau R; Martin-Blondel G;
    N Engl J Med; 2019 Apr; 380(17):1674-1676. PubMed ID: 30969500
    [No Abstract]   [Full Text] [Related]  

  • 3. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
    Cortese I; Muranski P; Enose-Akahata Y; Ha SK; Smith B; Monaco M; Ryschkewitsch C; Major EO; Ohayon J; Schindler MK; Beck E; Reoma LB; Jacobson S; Reich DS; Nath A
    N Engl J Med; 2019 Apr; 380(17):1597-1605. PubMed ID: 30969503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive multifocal leukoencephalopathy associated with a lymphoproliferative disorder treated with pembrolizumab.
    Holmes A; Wellings T; Walsh O; Rowlings P
    J Neurovirol; 2020 Dec; 26(6):961-963. PubMed ID: 32910430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel treatments for progressive multifocal leukoencephalopathy.
    Bennett KM; Fernandes PM
    Br J Hosp Med (Lond); 2020 Jul; 81(7):1-9. PubMed ID: 32730143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly active antiretroviral therapy does not improve survival of patients with high JC virus load in the cerebrospinal fluid at progressive multifocal leukoencephalopathy diagnosis.
    Taoufik Y; Delfraissy JF; Gasnault J
    AIDS; 2000 Apr; 14(6):758-9. PubMed ID: 10807206
    [No Abstract]   [Full Text] [Related]  

  • 7. IL-7 immunotherapy for progressive multifocal leukoencephalopathy in a patient with already controlled HIV-1 infection on antiretroviral therapy.
    Guille M; Rousset S; Bonneville F; Mengelle C; Taoufik Y; Delobel P; Martin-Blondel G
    AIDS; 2019 Oct; 33(12):1954-1956. PubMed ID: 31490218
    [No Abstract]   [Full Text] [Related]  

  • 8. Brain Lesion in the Setting of Chronic Rituximab Treatment.
    Yazdani M; Antonucci M; Spampinato MV
    JAMA Oncol; 2020 Jul; 6(7):1093-1094. PubMed ID: 32463440
    [No Abstract]   [Full Text] [Related]  

  • 9. Fatal progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma treated with rituximab.
    Paues J; Vrethem M
    J Clin Virol; 2010 Aug; 48(4):291-3. PubMed ID: 20558102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive multifocal leukoencephalopathy secondary to idiopathic CD4 lymphocytopenia treated with pembrolizumab.
    Varmpompiti K; Westwood AJ; Ben-Joseph A; Sibtain N; Ibrahim MAA; Stanton B; Zuckerman M; Hadden R; Ritter LM
    J Neuroimmunol; 2023 Dec; 385():578248. PubMed ID: 37995595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of HIV-associated progressive multifocal leukoencephalopathy with pembrolizumab.
    Sim BZ; Smith LK; Yarwood T; Smith S
    AIDS; 2022 Mar; 36(3):483-485. PubMed ID: 35084387
    [No Abstract]   [Full Text] [Related]  

  • 12. [The clinical spectrum of progressive multifocal leukoencephalopathy: differences and similarities in patients with and without human immunodeficiency virus].
    Camporro J; Bruno V; Cammarota A; Del Castillo M; Alessandro L
    Rev Neurol; 2019 Aug; 69(4):152-158. PubMed ID: 31334558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis.
    Wijburg MT; Kleerekooper I; Lissenberg-Witte BI; de Vos M; Warnke C; Uitdehaag BMJ; Barkhof F; Killestein J; Wattjes MP
    JAMA Neurol; 2018 Jul; 75(7):827-833. PubMed ID: 29532061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymptomatic progressive multifocal leukoencephalopathy associated with natalizumab.
    Mc Govern EM; Hennessy MJ
    J Neurol; 2013 Feb; 260(2):665-7. PubMed ID: 23212753
    [No Abstract]   [Full Text] [Related]  

  • 15. Atypical MRI features at early onset natalizumab-associated progressive multifocal leukoencephalopathy: a case report.
    Piola M; Di Palma F; Mascoli N; Binda S; Arnaboldi M; Rezzonico M
    J Neurol Sci; 2014 May; 340(1-2):213-4. PubMed ID: 24642511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of progressive multifocal leukoencephalopathy with chronic renal failure, whose JC virus in cerebrospinal fluid disappeared after mefloquine-mirtazapine dual therapy].
    Ohnuki E; Asayama S; Asayama T; Nakamichi K; Saijo M; Kosaka S
    Rinsho Shinkeigaku; 2016 Oct; 56(10):705-708. PubMed ID: 27645758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mefloquine in the treatment of progressive multifocal leukoencephalopathy.
    Gofton TE; Al-Khotani A; O'Farrell B; Ang LC; McLachlan RS
    J Neurol Neurosurg Psychiatry; 2011 Apr; 82(4):452-5. PubMed ID: 20562463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Pembrolizumab for Treatment of Progressive Multifocal Leukoencephalopathy in People Living with HIV.
    Pinnetti C; Cimini E; Vergori A; Mazzotta V; Grassi G; Mondi A; Forbici F; Amendola A; Grisetti S; Baldini F; Candela C; Casetti R; Campioni P; Capobianchi MR; Agrati C; Antinori A
    Viruses; 2022 May; 14(5):. PubMed ID: 35632711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab.
    Martinot M; Ahle G; Petrosyan I; Martinez C; Gorun DM; Mohseni-Zadeh M; Fafi-Kremer S; Tebacher-Alt M
    Emerg Infect Dis; 2018 Aug; 24(8):1594-1596. PubMed ID: 30016251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and magnetic resonance imaging monitoring in progressive multifocal leukoencephalopathy treated with pembrolizumab: a case report.
    Stögbauer J; Schulz-Schaeffer W; Mühl-Benninghaus R; Lochner P
    Neurol Sci; 2021 Jan; 42(1):357-359. PubMed ID: 32700225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.